AAV-mediated delivery of DNA to cells of the nervous system
US6503888B1 · kind B1 · utility
74Cited by
5References
26Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 13, 2000 |
| Grant date | Jan 7, 2003 |
| Priority date | — |
| Expiry date | Apr 13, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2840/203
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to a method of delivering exogenous DNA to a target cell of the mammalian central nervous system using an adeno-associated virus (AAV)-derived vector. Also included in the invention are the AAV-derived vectors containing exogenous DNA which encodes a protein or proteins which prevent or treat nervous system disease, and a method of prevent or treating such disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.